Skip to main content
Log in

PTPN22 C1858T and the risk of psoriasis: a meta-analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Psoriasis is a chronic autoimmune skin disease with both environmental and genetic risk factors. Previous studies of the association between psoriasis and PTPN22 C1858T (rs2476601), a gain of function variant associated with a stronger inhibitory effect of T-lymphocytes, have produced inconsistent results. The purpose of the current study is to evaluate the association between PTPN22 C1858T and psoriasis using meta-analysis to: (1) have a sufficient sample size for detecting a weak association; and (2) to explore the heterogeneity between studies. A meta-analysis based on random-effects model was performed with ten studies (3,334 psoriasis cases and 5,753 controls) identified from a literature search. A non-significantly positive association between psoriasis and the PTPN22 T1858 was observed [summary allelic odds ratio (OR) = 1.15, 95 % confidence interval (CI): 1.00–1.33] and the association appears stronger among subjects with psoriatic arthritis (summary allelic OR = 1.23, 95 % CI: 1.00–1.52). A null association between PTPN22 T1858 and early-onset psoriasis was observed (summary allelic OR = 1.08, 95 % CI: 0.92–1.28). The current analysis showed a non-significantly positive association between psoriasis and the PTPN22 T1858 allele, and the association appeared stronger among subjects with psoriatic arthritis. Future studies of psoriasis should incorporate gene-environment interaction in the analysis and pay attention to the heterogeneity of psoriasis cases and bias associated with population stratification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509

    Article  PubMed  CAS  Google Scholar 

  2. Gudjonsson JE, Elder JT (2007) Psoriasis: epidemiology. Clin Dermatol 25:535–546

    Article  PubMed  Google Scholar 

  3. Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34:J314–J321

    Article  PubMed  CAS  Google Scholar 

  4. Ibrahim G, Waxman R, Helliwell PS (2009) The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 61:1373–1378

    Article  PubMed  CAS  Google Scholar 

  5. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573

    Article  PubMed  Google Scholar 

  6. Rahman P, Elder JT (2005) Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 64 Suppl 2: ii37–ii39; discussion ii40–ii31

  7. Chandran V, Schentag CT, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM et al (2009) Familial aggregation of psoriatic arthritis. Ann Rheum Dis 68:664–667

    Article  PubMed  CAS  Google Scholar 

  8. Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Voorhees JJ (1994) The genetics of psoriasis. Arch Dermatol 130:216–224

    Article  PubMed  CAS  Google Scholar 

  9. Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP (2011) Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett 585(23):3689–3698

    Article  PubMed  CAS  Google Scholar 

  10. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P et al (2005) Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37:1317–1319

    Article  PubMed  CAS  Google Scholar 

  11. Arechiga AF, Habib T, He Y, Zhang X, Zhang ZY, Funk A et al (2009) Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 182:3343–3347

    Article  PubMed  CAS  Google Scholar 

  12. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M et al (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76:561–571

    Article  PubMed  CAS  Google Scholar 

  13. Hinks A, Barton A, John S, Bruce I, Hawkins C, Griffiths CE et al (2005) Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 52:1694–1699

    Article  PubMed  CAS  Google Scholar 

  14. Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P (2006) Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case–control study. Arthritis Res Ther 8:R27

    Article  PubMed  Google Scholar 

  15. Huffmeier U, Steffens M, Burkhardt H, Lascorz J, Schurmeier-Horst F, Stander M et al (2006) Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients. J Med Genet 43:517–522

    Article  PubMed  CAS  Google Scholar 

  16. Huffmeier U, Reis A, Steffens M, Lascorz J, Bohm B, Lohmann J et al (2006) Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. J Invest Dermatol 126:932–935

    Article  PubMed  Google Scholar 

  17. Smith RL, Warren RB, Eyre S, Ke X, Young HS, Allen M et al (2008) Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br J Dermatol 158:962–968

    Article  PubMed  CAS  Google Scholar 

  18. Zervou MI, Castro-Giner F, Sidiropoulos P, Boumpas DT, Tosca AD, Krueger-Krasagakis S (2010) The protein tyrosine phosphatase, non-receptor type 22 R620W polymorphism does not confer susceptibility to psoriasis in the genetic homogeneous population of Crete. Genet Test Mol Biomarkers 14:107–111

    Article  PubMed  CAS  Google Scholar 

  19. Juneblad K, Johansson M, Rantapaa-Dahlqvist S, Alenius GM (2011) Association between the PTPN22 + 1858 C/T polymorphism and psoriatic arthritis. Arthritis Res Ther 13:R45

    Article  PubMed  CAS  Google Scholar 

  20. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  21. Bradburn MJ (2004) Updated and new commands for meta-analysis in Stata. Available: http://www.medepi.net/meta/software/Bradburn_metan_updates.pdf. Accessed 23 April 2011

  22. Lewis S, Clarke M (2001) Forest plots: trying to see the wood and the trees. BMJ 322:1479–1480

    Article  PubMed  CAS  Google Scholar 

  23. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

    Article  PubMed  Google Scholar 

  24. Sterne JAC, Egger M, Smith GD (2005) Investigating and dealing with publication and other biases. In: Egger M, Smith GD, Altman DG (eds) Systematic reviews in health: care meta-analysis context. BMJ Books, London, pp 285–312

    Google Scholar 

  25. Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450–456

    Article  PubMed  CAS  Google Scholar 

  26. Naldi L, Mercuri SR (2009) Smoking and psoriasis: from epidemiology to pathomechanisms. J Invest Dermatol 129:2741–2743

    Article  PubMed  CAS  Google Scholar 

  27. Costenbader KH, Chang SC, De Vivo I, Plenge R, Karlson EW (2008) Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res Ther 10:R52

    Article  PubMed  Google Scholar 

  28. Thomas DC, Witte JS (2002) Point: population stratification: a problem for case–control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 11:505–512

    PubMed  Google Scholar 

  29. Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC, Mustelin T (2008) Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol 26:29–55

    Article  PubMed  CAS  Google Scholar 

  30. Nistor I, Nair RP, Stuart P, Hiremagalore R, Thompson RA, Jenisch S et al (2005) Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association. J Invest Dermatol 125:395–396

    PubMed  CAS  Google Scholar 

  31. Price AL, Butler J, Patterson N, Capelli C, Pascali VL, Scarnicci F et al (2008) Discerning the ancestry of European Americans in genetic association studies. PLoS Genet 4:e236

    Article  PubMed  Google Scholar 

  32. Li Y, Liao W, Chang M, Schrodi SJ, Bui N, Catanese JJ et al (2009) Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22. J Invest Dermatol 129:629–634

    Article  PubMed  CAS  Google Scholar 

  33. Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC et al (2005) PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 77:567–581

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey S. Chang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 92 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, YF., Chang, J.S. PTPN22 C1858T and the risk of psoriasis: a meta-analysis. Mol Biol Rep 39, 7861–7870 (2012). https://doi.org/10.1007/s11033-012-1630-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1630-z

Keywords

Navigation